Starbloom Capital is a U.S.-focused venture capital firm investing in deep tech, longevity biotech, neuroAI, life sciences, health technology, diagnostics, therapeutics, medical devices, clean energy and crypto/blockchain companies. It has backed companies from seed through Series C and has acted as a co-lead investor in a later-stage health technology financing, making it relevant for founders in biotechnology, neuroscience, AI-enabled life sciences, consumer health, therapeutics, diagnostics and emerging technology markets.